newsfilter
← Latest News
Business Wire·

Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022

Catalyst-rich year with data readouts expected from three Phase 2 studies across chronic pain and cognitive impairment development programs Advancing PTSD development program with initiation of Phase 2b studies Strong balance sheet expected to fun